12517 scientists
გ. ხელაშვილი
No biographical information has been added yet.
1 ლამბლიოზური ქოლეცისტიტების მკურნალობის საკითხისათვის
2 Thermodynamic and Hydrodynamic Study of DNA-Anticancer Antibiotic (Adriablastin) Interaction-დნმ-ისა და ანტიკანცეროგენული ანტიბიოტიკის (ადრიაბლასტინი) ურთიერთქმედების თერმოდინამიკური და ჰიდროდინამიკური შესწავლა
3 შუა ყურის ქოლესტეატომური დაავადებების მკურნალობა
4 Sodium Tetrathioarsenate as a Precipitant of Ammoniate Ions of Transitional Metals
Nothing found.
ვ. ხელაშვილი
No biographical information has been added yet.
1 Closure of atrial septal deffect surgicaly and by transcathaterr methods in two year experience
2 Patent ductus arteriosus endovascular closure by Amplatzer duct occluder
Nothing found.
ბ. ხელაშვილი
No biographical information has been added yet.
1 The results of surgical treatment of middle ear cholesteatoma by using open and closed techniques
2 Schwannomes bénins des fosses nasales: à propos d’un cas
3 Рецидив холестеатомы среднего уха двадцать лет спустя после радикальной операции
4 Surgical treatment of larynx T1N0M0 cancer - partial laryngectomy modified Majer-Piquet’s intervention
Nothing found.
ნინო ხელაძე
No biographical information has been added yet.
1 D ვიტამინის დეფიციტის გავლენა საყრდენ-მამოძრავებელი სისტემის სხვადასხვა პათოლოგიის განვითარებაზე ბავშვებსა და მოზარდებში
2 THE INFLUENCE OF ENVIRONMENTAL FACTORS ON PRECOCIOUS PUBERTY: A CASE REPORT
3 AUTOIMMUNE THYROID DYSFUNCTIONS IN CHILDREN WITH DOWN SYNDROME
4 VAN WYK –GRUMBACH SYNDROME IN A CHILD WITH DOWN SYNDROME: WHEN HYPOTHYROIDISM MASQUERADES AS HEMATURIA AND OVARIAN CYSTS
5 Влияние наполнителей на свойства ПВХ-композиций
6 Стабильность ПВХ-композиций при переработке
7 Стеклоармированный полипропилен
8 მინაარმირებული თერმოპლასტების წნეხვა და ნაკეთობების ტექნოლოგიური დამუშავება
9 სტაბილიზატორები შევსებული პოლივინილქლორიდისათვის
10 შევსებული პოლისტიროლური კომპოზიციების ხანგამძლეობა და ფიზიკო-მექანიკური თვისებები
11 ფიზიკურ–ქიმიური პროცესები სისტემაში პოლიოლეფინი–შემავსებელი
12 თერმოპლასტების გადამუშავების ზოგიერთი მეთოდი
13 თერმოპლასტების გადამუშავების ზოგიერთი მეთოდი
14 წვრილდისპერსიული წიდის შემავსებლის გამოყენებით მიღებული პოლისტიროლური კომპოზიციების მოდიფიცირება
15 მეთამბაქოეობის აღდგენა-განვითარების პერსპექტივები საქართველოში
16 Стабильность наполненных шлаками пвхкомпозиций
17 ზესტაფონის ფეროშენადნობთა ქარხნის წიდის გამოყენება პოლიმერული მასალების შემავსებლებად
18 Исследование основных характеристик новых композиций на основе ПВХ с минеральными наполнителями
19 Наполнение полипропилена синтетическими волокнами
20 Новые наполнители для поливинилхлорида
21 Поверхностные явления в наполненных шлаками Зестафоноского завода ферросплавов полиолефинах
22 ფურცლოვანი მინაარმირებული პოლიპროპილენის გაცივების პროცესი
23 Стабильность и долговечность пвх-композиций
24 შევსებული თერმოპლასტების ჩამოსასხმელი ფორმები
25 თერმოპლასტები გადამუშავება წნევის გარეშე ჩამოსხმით
26 შევსებული პოლივინილქლორიდული კომპოზიციების ოპტიმალური პარამეტრების გაანგარიშება
27 პვ-88 კარდიოპროტექტული მოქმედება ჰემორაგიული შოკის დროს ექსპერიმენტში
28 D ვიტამინისა და კალციუმის დეფიციტის პრევენციისა და მკურნალობის თანამედროვე რეკომენდაციები
29 Смазочные материалы для поливинилхлоридных композиций
Nothing found.
მაია ხელაძე
No biographical information has been added yet.
1 CELLULAR AND HUMORAL IMMUNE RESPONSES TO COVID-19
2 ლაბორატორიული კვლევები სამეგრელოს რეგიონში დაფნის კულტურის გავრცელებისათვის
3 რა განსაზღვრავს კრიპტოვალუტის ბაზრებს? მონაცემები, კაპიტალის ზრდა და მაკროეკონომიკა
4 ხელოვნური ინტელექტის შემცველი ბიზნესმოდელები საგადახდო ინდუსტრიაში და უნაღდო ანგარიშსწორების გავლენა ეკონომიკის ზრდაზე (მშპ) საქართველოში
5 თხილის დაცვა მავნებლებისაგან
6 Напряженно-деформированное состоянние мягкой оболочки сферической пневмоопалубки
Nothing found.
ზაზა ხელაძე
No biographical information has been added yet.
1 პოსტოპერაციული ჰოსპიტალური ინფექციები
Nothing found.
ზვიად ხელაძე
No biographical information has been added yet.
1 პოსტოპერაციული ჰოსპიტალური ინფექციები
2 კრიტიკული მედიცინა = Critical Medicine
3 კრიტიკული მედიცინა = Critical Medicine. წიგნი 1
4 კრიტიკული მედიცინა = Critical Medicine წიგნი 2
5 სეფსისი = Sepsis : მომზადდა სეფსისის მსოფლიო დღის დაწესების ნიშნად
Nothing found.
ზურაბ ხელაძე
No biographical information has been added yet.
1 ქვეცნობიერების მართვის პრობლემები კრიტიკულ მედიცინაში
2 იმუნოლოგია რეანიმატოლოგთათვის
3 New steps in critical care medicine
4 კრიტიკული მედიცინა = Critical Medicine
5 კრიტიკული მედიცინა = Critical Medicine. წიგნი 1
6 კრიტიკული მედიცინა = Critical Medicine წიგნი 2
7 სეფსისი = Sepsis : მომზადდა სეფსისის მსოფლიო დღის დაწესების ნიშნად
8 კრიტიკული მედიცინა = Critical care medicine
9 კონცეპტუალური მოსაზრებანი შესავლის ნაცვლად
10 საქართველოს ექსკლუზიური მოდელი კრიტიკული მედიცინისათვის
11 კრიტიკული მედიცინა : (ექიმთა და სტუდენტთა სახელმძღვანელო)
12 დიაბეტური ტერფის მკურნალობა პლაზმური ნაკადით
13 მონაცემები კრიტიკული მედიცინის კლინიკის მუშაობის დაგეგმარებისათვის.
Nothing found.
თ. ხელაძე
No biographical information has been added yet.
1 სისხლის შედედების სისტემისა და ღვიძლის ფუნქციური ცვლილებები პორტული ჰიპერტენზიის დროს
2 დიაფრაგმის ტრავმული თიაქრის ოპერატიული მკურნალობის შემთხვევა
Nothing found.
თამაზ ხელაძე
No biographical information has been added yet.
1 დილატაციური კარდიომიოპათია და კოაგულაციის მე-8 ფაქტორის დეფიციტი, როგორც იშვიათი გენეტიკური კომბინაცია - Dilated cardiomyopathy and coagulation factor VIII deficiency as a rare genetic combination
2 ამფეტამინის ტიპის სტიმულანტებთან ასოცირებული კარდიომიოპათია კლინიკური შემთხვევის განხილვა - Dilated cardiomyopathy and coagulation factor VIII deficiency as a rare genetic combination
3 მიოკარდიტი როგორც არითმოგენული კარდიომიოპათიის განვითარების ერთ-ერთი რისკფაქტორი - Myocarditis as a risk factor for the development of arrhythmogenic cardiomyopathy
Nothing found.
ქეთი ხელაძე
No biographical information has been added yet.
1 პაციენტების მენეჯმენტის შეფასება და მისი როლი სამედიცინო მომსახურების ხარისხის გაუმჯობესებაში
Nothing found.
ზ. ხელაძე
No biographical information has been added yet.
1 კრიტიკულ მდგომარეობათა პროგნოზირება 14 კდ მოლეკულური მასის მქონე პოლიპეპტიდისლაბორატორიული კვლევების საშუალებით
2 კრიტიკულ მდგომარეობაში მყოფ ავადმყოფთა ანესთეზიოლოგიური უზრუნველყოფა
3 პლაზმური ნაკადის გამოყენება პროკურსორული უჯრედების სტიმულაციისათვის, კრიტიკული მდგომარეობა
4 Using Plasma Radiations at Prevention and Treatment of the Critically Ill Patients With Ventilator Associated Pneumonia
5 The Tactics of Treating Stress Ulcers In The Patients Who Are on Mechanical Ventilation
6 Postoperative Hospital Acquired Infections
7 პანდემია,რომელსაც არ ელოდნენ
8 პანდემიების მიერ შექმნილი ისტორია
9 ვირუსის ორგანიზმში ჩანერგვის პროცესი
10 ახალი კორონა ვირუსების აგრესიული ბუნება
11 ეპიდსაწინააღმდეგო ღონისძიებები
12 დიაგნოზის სირთულენი
13 მკურნალობის მართვა
14 ვაქცინით მოტანილი იმედი
15 პოსტკოვიდური სინდრომი
16 მომავალი კატასტროფები-ახალი ნატო 21-ე საუკუნის მსოფლიოსათვის
17 ავადმყოფთა თავის ტვინის ელექტროსტიმულაციის პირველი შედეგები
18 ავადმყოფთა მეხსიერების შესწავლა კრიტიკულ მდგომარეობათა დროს და მის მემდგომ პერიოდში
19 პოსტკოვიდური სინდრომი
20 საქართველოს კრიტიკული მედიცინის ინსტიტუტში მიღებულ მეცნიერულ სიახლეთა რეტროსპექტული ანალიზი
21 პრემორბიდულ მედიცინის ავადმყოფთა მკურნალობის შედეგები საქართველოს კრიტიკული მედიცინის ინსტიტუტში
22 სიკვდილის პრობლემათა ახალი ხედვა
23 Zvlis tvinis ელექტროსტიმულაცია kritikul mdgomareobaTa dros
24 სახელმძღვანელო სეფსისის შესახებ კრიტიკული მედიცინის ექიმებისათვის
25 სურათები „კვანტური მედიცინისთვის“
26 ავადმყოფთა ინტელექტუალური შესაძლებლობებისა და მეხსიერების შესწავლა კრიტიკულ მდგომარეობათა დროს
27 ,,Deja Vus” ფენომენის გამოვლინების თავისებურებანი კრიტიკულ მდგომარეობათა დროს
28 „Jame Vus” ფენომენის გამოვლინების თავისებურებანი კრიტიკულ მდგომარეობათა დროს
29 სიახლე დაავადებათა მკურნალობაში: ძვლის ტვინის პროგენიტური პრეკურსორების კომიტირება
30 One year since the announcement of the New Corona Virus pandemic: reality and prospects
31 A pandemic, that was not expected
32 The use of argon plasma flow in the complex treatment of pneumonia in critically ill patients on artificial lung ventilation
33 Comparative analysis of extracorporeal hemoperfusion methods
34 Study of immune memory induced by immunocompetent T-lymphocytes in critical conditions
35 Electrical stimulation of the bone marrow should become an essential component of the treatment process for critically ill patients.
36 Named the "Death Factor" cytokine - is it possible for it to be involved in the act of sudden death in those infected with the New Corona Virus?
37 "New NATO" for the world of the 21st century
38 Peculiarities of treatment of the patients infected with the "SARS-CoV-2" virus.
39 However, only one “SARS-CoV-2 “virus has been identified by the World Health Organization as a cause of the “COVID-19 pandemic”,but at least three different strains of the same virus have been reported to work during the pandemic
40 Sepsis, which is a cause for concern in modern medicine Georgian Critical Care Medicine Institute, Tbilisi, Georgia
41 Analysis of the work of the Medical Service of Georgia from the “Developed Socialism,s Era" before the onset of the "COVID-19" pandemic, caused by "SARS-Cov-2" virus
42 „ახალი სიკვდილი” და „ახალი სიცოცხლე”
43 კრიტიკული მედიცინის სამსახური საქართველოში წარსული აწმყო და მომავალი
44 ენდოგენური ტოქსემიის სადიაგნოზო სწრაფი, მარტივი და იაფი მეთოდი
45 იმუნოსორბციის გამოყენება სეფსისით გამოწვეულ კრიტიკულ მდგომარეობათა სამკურნალოდ
46 იმუნური სტატუსის შეფასება ანესთეზიოლოგებსა და კრიტიკული მედიცინის ექიმებში
47 Plasma flow treatment of the diabetic foot
48 Conceptual opinions related to the scientific reasersh journal "Critical Care& Catastrophe Medicine" 60-61 numbers
49 Peculiarities changes the number of immune-competent T- and B- lymphocytes during dying process
50 Study of the number of T- and B- lymphocytes in adults and elderly dying’s patients
51 Number of the rosette forming cells in different sex patients during dying process
52 Study of dying patients responder cells activity in the lymphocytes one direction primery mixed culture
53 Study of responder cells activity in the lymphocytes one direction primery mixed culture in adults and elderly dying patients
54 Study of responder cells activity in the lymphocytes one direction primery mixed culture in different sexes dying patients
55 Study of dying patients immune memomry cells activity in the lymphocytes one direction secondary mixed culture
56 Study of immune memory cells activity in the one direction segondery mixed culture lymphocytes in adults and elderly dying patients
57 Study of immune memory cells activity in the one direction segondery mixed culture lymphocytes in different sexes dying patients
58 Study of blood serum concentration A,M and G immunoglobulins during dying process
59 Study of blood serum concentration A, M and G immunoglobulins in adult and elderly dying patients
60 Study of blood serum concentration A, M and G immunoglobulins in different sexes dying patients
61 Study of mitogen activity T-lymphocytes in patients during dying process
62 Study of mitogen activity T- lymphocytes in adults and elderly patients diuring dying process
63 Study of mitogen activity T- -lymphocytes in different sexes patients duiring dying process
64 Study of suppressor lymphocytes activity in patients diuring dying process
65 Study of suppressor lymphocytes activity in adults and elderly patients diuring dying process
66 Study of suppressor lymphocytes activity in different sexes patients duiring Dying process
67 Study of immune response cheing during dying process which death and revived patients
68 Study of immune response changes in the experimental dogs during morbidity process through bleeding
69 Study of immune response changes in the experimental dogs during dying process,which modelded by short and long formes through bleeding from femoral artery
70 Mildronate restores elderly persons T-lymphocytes ability to generate E-rosettes cells
71 Mildronate restores T-Lymphocytes E-rosettes forming function of the critical Patients.
72 Siofor restores elderly persons T-lymphocytes ability to generate E-rosettes cells
73 Siofor restores T-Lymphocytes E-rosette forming function of the critical Patients
74 Nitroglycerin restores elderly persons T-lymphocytes ability to generate E-rosettes cells
75 Nitroglycerin restores T-Lymphocytes E-rosette forming function of the critical Patients
76 Adrenalin don’t restores elderly persons T-lymphocytes ability to generate E-rosettes cells
77 Adrenalin don’t restores T-Lymphocytes E-rosette forming process of the critical Patients
78 Dexametason suppresses elderly persons T-lymphocytes ability to generate E-rosettes cells
79 Dexametason suppresses T-Lymphocytes E-rosette forming process of the critical patients
80 Furosemyd suppresses elderly persons T-lymphocytes ability to generate E-rosettes cells
81 Cordaron suppresess elderly persons T-lymphocytes ability to generate E-rosettes cells
82 Cordaron suppresses T-Lymphocytes E-rosette forming process of the critical patients
83 Furosemyd suppresess elderly persons T-lymphocytes ability to generate E-rosettes cells
84 Furosemyd suppresses T-Lymphocytes E-rosette forming process of the critical patients
85 Verampamyl suppresses elderly persons T-lymphocytes ability to generate E-rosettes cells
86 Verampamil suppresses T-Lymphocytes E-rosette forming process of the critical patients
87 Dopamine don’t restores elderly persons T-lymphocytes ability to generate E-rosettes cells
88 Dopamine don,t restores critical patients T-lymphocytes ability to generate E-rosettes cells
89 Dobutamyne don’t restores elderly persons T-lymphocytes ability to generate E-rosettes cells
90 Dobutamine don’t restores critical patients T-lymphocytes ability to generate E-rosettes cells
91 Noradrenalin don’t restores elderly persons T-lymphocytes ability to generate E-rosettes cells Critical Care&Catastrophe Medicine ", Tbilisi, Georgia,2019, N58-59
92 Noradrenalin don,t restores critical patirnts T-lymphocytes ability to generate E-rosettes cells
93 Diazepam don,t restores elderly persons T-lymphocytes ability to generate E-rosettes cells
94 Diazepam don,t restores critical patients T-lymphocytes ability to generate E-rosettes cells
95 Propophol don,t restores elderly persons T-lymphocytes ability to generate E-rosettes cells
96 Propophol don’t restores critical patients T-lymphocytes ability to generate E-rosettes cells
97 Ketamyn don,t restores elderly persons T-lymphocytes ability to generate E-rosettes cells
98 Ketamyn don,t restores critical patients T-lymphocytes ability to generate E-rosettes cells
99 Midazolam don,t restores elderly persons T-lymphocytes ability to generate E-rosettes cells
100 Mydazolam Diazepam don,t restores critical patirnts T-lymphocytes ability to generate E-rosettes cells
101 Movalys don,t estores elderly persons T-lymphocytes ability to generate E-rosettes cells
102 Movalys don,t restores critical patirnts T-lymphocytes ability to generate E-rosettes cells
103 Aspirin suppresses critical patients T-lymphocytes ability to generate E-rosettes cells
104 Thiopental suppresses T-Lymphocytes E-rosette forming process of the elderly patients
105 Thiopental suppresses T-Lymphocytes E-rosette forming process of the critical patients
106 Sulphat Magnya don’t restores elderly persons T-lymphocytes ability to generate E-rosettes cells
107 Sulphat Magnya don,t restores T-Lymphocytes E-rosette forming process of the critical Patients
108 Aspirin suppresses elderly persons T-lymphocytes ability to generate E-rosettes cells
109 Aspirin suppresses T-Lymphocytes E-rosette forming process of the critical patients
110 Recormon restores elderly persons T-lymphocytes ability to generate E-rosettes cells
111 Recormon restores T-Lymphocytes E-rosettes forming function of the critical Patients
112 The second option rule of receiving "Death factor"
113 The first option rule of receiving "Death factor"
114 Study of lethal and divergent effect of "Death factor"
115 Creation of antitoxin and immunoglobulin against the "Death factor"
116 Comparative analysis of immunosorbtion in various phases of sepsis treatment process
117 Inspection of against "Death factor" antitoxin and immunoglobulin rejuvenating effect in the old age
118 Inspection against of the "Death factor"antitoxin and immunoglobulin rejuvenating effect
119 Study of anti-aging effect of antitoxin and immunoglobulin against the "Death factor"
120 Peculiarities of the "Death factor" change in morbidity and resuscitation
121 Which CD markers do old lymphocytes lose during critical care conditions What causes of aging of lymphocytes of critical patients
122 Which CD markers do old lymphocytes lose during critical care conditions? What causes of aging of lymphocytes of critical patients
123 What causes of aging of lymphocytes of critical patients Critical Care Medicine Institute, Tbilisi, Georgia
124 Lymphocytes of critical patients are older than healthy ones
125 What causes of aging of lymphocytes of critical patients
126 Critically ill patients blood plasma causes aging young white mouse
127 Blood plasma of old ages persons does not suppress of the respondent cells activity in the one direction mixed culture of lymphocytes during the participation of anti lethal immunoglobulin
128 Blood plasma of old ages persons suppresses the respondent cells activity in the one direction mixed culture of lymphocytes
129 Old ages persons blood plasma causes aging young white mouse
130 "Death Factor " can not suppress the respondent cells activity in one direction mixed culture of lymphocytes during the participation of anti lethal immunoglobulin
131 Blood plasma of critical patients does not suppress of the respondent cells activity in the one direction mixed culture of lymphocytes during the participation of anti lethal immunoglobulin
132 Blood plasma of critical patients suppresses the respondent cells activity in the one direction mixed culture of lymphocytes
133 The "Death factor” causes aging of the young white mouse
134 Critically ill patients blood plasma dos not causes aging young white mouse after processing witch anti lethal immunoglobulin
135 The "Death factor” after proceeding anti lethal immunoglobulin don’t aging of the young white mouse
136 Old ages persons blood plasma dos not causes aging young white mouse, after processing witch anti lethal immunoglobulin
137 Young ages persons blood plasma stops the aging process of old ages white mouse
138 Old ages persons blood plasma after proceeding “Death Factor” causes aging young white mouse
139 Young ages persons blood plasma after proceeding from “Death Factor” don’t stops the aging process of old ages white mouse
140 Young ages persons blood plasma after proceeding from anti lethal immunoglobulin stops the aging process of old ages white mouse
141 The "Death Factor" suppresses respondent cells in the one direction lymphocytes mixed culture
142 Problems of preparation personals for Critical Medicine in XXI century
143 Peculiarities changes stem and immunocompetent cells by nitroglycerin action on the critical patient’s bone marrow
144 Results of treatment critical ill patients by after other factors action on the bone marrow
145 Peculiarities changes peripheral blood cells by plasma ray action on the critical patient’s bone marrow
146 Peculiarities changes Acid- alkyls ------ by plasma ray action on the critical patient’s bone marrow
147 Peculiarities changes stem and immunocompetent cells by electrical impulses action on the critical patient’s bone marrow
148 Peculiarities changes periphereal blood cells by electrical impulses action on the critical patient’s bone marrow
149 Peculiarities changes Acid- alkyls ----- cells by electrical impulses action on the critical patient’s bone marrow
150 Peculiarities changes bone marrow cells by nitroglycerin action on the critical patient’s bone marrow
151 პერიფერიული სისხლის უჯრედების ცვლილებათა თავისებურებანი კრიტიკულ ავადმყოფთა ძვლის ტვინის ნიტროგლიცერინით დამუშავების შემდეგ
152 ძვლის ტვინის მჟავა-ტუტოვანი წონასწორობის ცვლილებათა თავისებურებანი კრიტიკულ ავადმყოფთა ძვლის ტვინის ნიტროგლიცერინით დამუშავების შემდეგ
153 ძვლის ტვინის უჯრედების რაოდენობის ცვლილებათა თავისებურებანი კრიტიკულ ავადმყოფთა ძვლის ტვინის ადრენალინით დამუშავების შემდეგ
154 ღეროვან და იმმუნოკომპეტენტურ უჯრედების ცვლილებათა თავისებურებანი კრიტიკულ ავადმყოფთა ძვლის ტვინის ადრენალინით დამუშავების შემდეგ
155 Death in critical care medicine clinic
156 Does Dark matter cause sudden death and does it kill 18 year old climber - case analysis after 35 years Georgian Critical Care Medicine Institute Proceedings of the Scientific Conference of the Georgian Academy of Medical Scie
157 What information do patients recall in life-threatening conditions better: new or old, positive or negative?
158 The Project of Poverty Reduction Program of Three Years for Georgia Georgian Critical Care Medicine Institute
159 A new method of treating critical conditions presented as electrical stimulation of the bone marrow, that can be used to treat many other diseases.
160 Human DNA must contain codes other than the protein code. that allow each cell's chromosome apparatus to store all the information in the universe
161 Standard requirements of treatment of acute mediastinitis for critical care medicine clinics of limited resources
162 Standard requirements of treatment of meningitis, encephalitis and meningoencephalitis for Critical Care Medicine clinics with limited resources
163 Standard requirements of treatment of Myasthenic Crisis for critical care medicine clinics of limited resources
164 Standard requirements of treatment of Myxoma for Critical Care Medicine clinics with limited resources
165 Standard requirements of treatment of Freezing injury for Critical Care Medicine clinics with limited resources
166 Standard requirements of treatment of Large intestine’s diseases For critical care medicine clinics of limited resources
167 Standard requirements of Sun-related injuries treatment of sun-related injuries for Critical Care Medicine clinics with limited resources
168 Standard requirements of treatment of Nelson Syndrome and Symonds disease for critical care medicine clinics of limited resources
169 Standard requirements of treatment of Pregnant and obstetric patients for Critical Care Medicine clinics with limited resources
170 Standard requirements of treatment of acute pancreatitis for critical care medicine clinics of limited resources
171 Standard requirements of treatment of parathyroid Stroke for critical care medicine clinics of limited resources
172 Standard requirements of treatment of acute peritonitis for critical care medicine clinics of limited resources
173 Standard requirements of treatment of acute pneumonia for critical care medicine clinics of limited resources
174 Standard requirements of treatment of severe travma for Critical Care Medicine clinics with limited resources
175 Standard requirements of treatment of Poliomielitys for Critical Care Medicine clinics with limited resources
176 Standard requirements of treatment of postreanimation Disease for critical care medicine clinics of limited resources
177 Standard requirements of treatment of Cholera for critical care medicine clinics of limited resources
178 Standard requirements of treatment of Adult’s Respiratory Distress Syndrome for Critical Care Medicine clinics with limited resources
179 Standard requirements of treatment of Rickettsioses for critical care medicine clinics of limited resources
180 Standard requirements of treatment of Liver failure for Critical Care Medicine clinics with limited resources
181 Standard requirements of treatment of Obstruction of Respiratory Way for critical care medicine clinics of limited resources
182 Standard requirements of treatment of Esophageal diseases for critical care medicine clinics of limited resources
183 Standard requirements of treatment of sepsis for Critical Care Medicine clinics with limited resources
184 Standard requirements of treatment of HIV infection for critical care medicine clinics of limitedresources
185 Standard requirements of treatment of Febrile Schizophrenia for critical care medicine clinics of limited resources
186 Standard requirements of treatment of Blood Disease for critical care medicine clinics of limited resources
187 requirements of treatment of Thermal attack and overheating for Critical Care Medicine clinics with limited resources
188 Standard requirements of treatment of Fungi for critical care medicine clinics of limited resources
189 Standard requirements of treatment of Severe Spinal Trauma for Critical Care Medicine clinics with limited resources
190 Standard requirements of treatment of severe skull and brain trauma for Critical Care Medicine clinics with limited resources
191 Standard requirements of treatment of acute radiant disease for critical care medicine clinics of limited resources
192 Standard requirements of treatment of diabetes insipidus for critical care medicine clinics of limited resources
193 Standard requirements of treatment of Tetanus for critical care medicine clinics of limited resources
194 Standard requirements of care and treatment of vegetativ condition for Critical Care Medicine clinics with limited resources
195 Standard requirements of treatment of Acute Failure of the Cortex of the Adrenal Gland for critical care medicine clinics of limited resources
196 Standard requirements of treatment of small intestine’s diseases for critical care medicine clinics of limited resources
197 Standard requirements of treatment of Kidney failure for Critical Care Medicine clinics with limited resources
198 Standard requirements of treatment of Poisoning for Critical Care Medicine clinics with limited resources
199 Standard requirements of treatment of Embola for critical care medicine clinics of limited resources
200 Standard requirements of treatment of Smallpox for Critical Care Medicine clinics with limited resources
201 Standard requirements of treatment of Tuberculosis for critical care medicine clinics of limited resources
202 Standard requirements of treatment of Primary and second hyperaldostrenism for Critical Care Medicine clinics of limited resources
203 Standard requirements of treatment of acute porfiria for critical care medicine clinics of limited resources
204 Standard requirements of treatment of Aneurism and Thrombosis for Critical Care Medicine clinics with limited resources
205 Standard requirements of treatment of anemia for critical care medicine clinics of limited resources
206 Standard requirements of treatment of Arrhythmias and Blockades for Critical Care Medicine clinics with limited resources
207 Standard requirements of treatment of status astmaticus for critical care medicine clinics of limited resources
208 Standard requirements of treatment of Neonatal Disorders for Critical Care Medicine clinics with limited resources
209 Standard requirements of treatment of hydrophobia for critical care medicine clinics of limited resources
210 Standard requirements of treatment of Diabetes coma for critical care medicine clinics of limited resources
211 Standard requirements of treatment of Burn Diseases for critical care medicine clinics of limited resources
212 Standard requirements of treatment of Eclampsy for critical care medicine clinics of limited resources
213 Standard requirements of treatment of Injury from electric current for Critical Care Medicine clinics with limited resources
214 Standard requirements of treatment of spleen diseases for critical care medicine clinics of limited resources
215 Standard requirements of treatment of Embola for critical care medicine clinics of limited resources
216 Standard requirements of treatment of epileptic status for Critical Care Medicine clinics with limited resources
217 Standard requirements of treatment of Echinoccocus for critical care medicine clinics of limited resources
218 Standard requirements of treatment of thyroid stroke for critical care medicine clinics of limited resources
219 Standard requirements of treatment of for Pheochromocytoma critical care medicine clinics of limited resources
220 Standard requirements of treatment of Pulmonary Embolism for critical care medicine clinics of limited resources
221 Standard requirements of treatment of Pulmonary Congestion for critical care medicine clinics of limited resources
222 Standard requirements of treatment of Flu for critical care medicine clinics of limited resources
223 Standard requirements of treatment of“Guillain-Barre” Syndrome for Critical Care Medicine clinics with limited resources
224 Standard requirements of treatment of Flu for critical care medicine clinics of limited resources
225 Standard requirements of treatment of Heart Diseases for critical care medicine clinics of limited resources
226 Standard requirements of treatment of Cardiac Arrest for critical care medicine clinics of limited resources
227 Standard requirements of treatment of severe chest trauma for critical care medicine clinics of limited resources
228 Standard requirements of treatment of Hemorrhagic Fever for critical care medicine clinics of limited resources
229 Standard requirements of treatment of Hepatitis for critical care medicine clinics of limited resources
230 Standard requirements of treatment of Hypothalamic-Hypophysal Coma for critical care medicine clinics of limited resources
231 Standard requirements of treatment of Skin Daises for critical care medicine clinics of limited resources
232 Standard requirements of treatment of Cardiogenic Shock for critical care medicine clinics of limited resources
233 Standard requirements of treatment of Cardiomyopathfor Critical Care Medicine clinics with limited resources
234 Standard requirements of treatment of Collagenoses Diseases for critical care medicine clinics of limited resources
235 Standard requirements of treatment of long-term crush syndrome for critical care medicine clinics of limited resources
236 Standard requirements of treatment of Cushing diseaseC and Cushing syndrome for critical care medicine clinics of limited resources
237 Standard requirements of treatment of gastric disease for critical care medicine clinics of limited resources
238 Standard requirements of treatment of legionellosis for critical care medicine clinics of limited resources
239 Standard requirements of treatment of leishmaniasis for critical care medicine clinics of limited resources
240 Standard requirements of treatment of Malaria for critical care medicine clinics of limited resources
241 Standard requirements of treatment of Hypovolemic shock for Critical Care Medicine clinics with limited resources
242 Modern methods of anesthesia in endoscopic research methods and treatment of patients in critical condition
243 Actual issues of anesthetic management optimization in therapeutic and diagnostic bronchoscopy among patients in critical condition Institute of Critical Care Medicine, Tbilisi, Georgia
244 Results of transplantation of brain cells of mice embryo in postreanimation period
245 Pecularities of hemostatic changes in critical patients of acute respiratory failure and acute cardiac failure
246 Pecularities of hemostatic changes in critical patients of chronic cardiac failure Critical Care
247 Disorders in memory during critical conditions Critical Care Medicine Institute, Tbilisi, Georgia
248 Immunosorbtion-The new technology treatment of sepsis. Critical Care Medicine Institute,Tbilisi,Georgia
249 Treatment of sepsis by the blood extracorporeal perfusion in the activated charcoal immunosorbent
250 Peculiarities of hemostasis’s changes in critical patients of hemorrhagic insult Critical Care Medicine Institute,Tbilisi,Georgia
251 Functional condition of kidneys in critical patients of chronic cardiac failure Critical Care Medicine Institute,Tbilisi,Georgia
252 Peculiarities of kidney function in critical patients of hemorrhagic insult
253 Peculiarities of kidney function in critical patients of ischemic insult
254 Functional condition of kidneys in critical patients of acute respiratory failure and chronic cardiac failure
255 Electric stimulation of brain-will it be a standard method of treatment of critical patients
256 Pecularities of changes in liver function of critical care patients which suffer from hemorrhagic insult
257 Peculiarities of changes in liver function of critical care patients which suffer from ischemic insult
258 Peculiarities of changes in liver function of critical care patients which suffer from cardiac failure
259 Peculiarities of changes in liver function of critical care patients which suffer from acute respiratory failure
260 Peculiarities of changes in liver function of critical care patients which suffer from acute respiratory failure and cardiac failure
261 The Predictors of Death
262 Works of third step for creation artificial intelligence
263 Requirements for providing technological process for critical care medicine service of limited resources
264 Anti-death immunoglobulin treatment and prophylactic effect in experiment
265 Electric-encephalographic changes by the influence of sound waves in unconscious critical patients
266 Plasma flow treatment of the acute gastro-duodenal ulceration at ventilator-dependent patients
267 Two cases of the neuroleptic malignant syndrome
268 Progress report of the critical care medicine institute’s clinic in 2009
269 Progenitor precursors' committing at critical stroke
270 Progenitor precursors’ committing at post-reanimation disease
271 Distinctives of medical assistance for the old-aged critical patients
272 Critical care medicine resources’ program design
273 Genetic and psychological basis of a frequent usage of the word “cool” in human speech
274 In the own cell chromosome apparatus of human might be kept all universes information
275 Long-term results of treatment of critical patients
276 Medicine, that needs to be treated itself
277 Mitochondria”, that is “observer” and takes out the energy in the universe
278 New data of the results of bone marrow electro stimulation in treatments of patients with critical health situation
279 Participation of borealis antigens in a routine of death birt
280 Peculiarities of changes of „Death factor“ in critical patients and experimental animals
281 Removing the fear of the phenomenon of the efforts of the human mind
282 Studying of a person’s character and destiny peculiarities in Critical Care Medicine personnel
283 Studying of the prophylactic effect of anti death anatoxin
284 The impact of the cost on treatment process for treatment results of the critical patients
285 The impact of the manegment systems for the critical patients treatment results
286 The influence of working conditions on Short and long term memory of Critical Care Medicine personnel
287 Information about the feasibility of transplanting brain and spinal cord with a together complex
288 ,,Death Code”-which ,,Lives” during life and kills this life
289 Georgia has great achievements in the sphere of arranging critical care medicine services but there are lot of issues which must be done ahead
290 However, the soul do not constitute unknown energy type that has mentality, but it is still should be studied
291 Peculiarities of providing anesthesia in old age critical patients
292 Peculiarities of Surgical Treatment in Critical Patients of old age
293 Peculiarities of treatment of critical insult of old age
294 Research of optimal ways for providing oxygen in behalf of critical medicine
295 Studying of function and morphology of thyroid gland in critical patients
296 Studying of function and morphology of Heart and Liver in co-workers of the critical care medicine
297 Studying of function and morphology of thyroid gland in critical patients
298 The influence of music waves on brain in critical patients in unconscious condition
299 The internet has throughly changed the everyday routine of critical care medicine service
300 The problems of critical care medicine
301 Virus hepatitis markers’ distribution between the clinic of Georgian Institute of Critical Care Medicine and medical personal
302 Human can have inverted data at the time of birht about passed way of ancestors as well as about his personal life ,,scenario” on the way to go along descendants
303 Analysis of critical pneumonia multicenter studies under the auspices of the European Society of Intensive Care Medicine conducted in Critical Medicine Institute of Georgia
304 Bone marrow electro stimulation shall become a standard treatment for criticalpatients
305 Brain electrical activity manifestation in orthodox christian patients diuring praying
306 Conceptual Considerations Instead of Introduction
307 Dopamine quantity study in critical patients
308 Influence of music on EEG of critical patients
309 Memory and intellect assessment of critical patients
310 Remote control systems for Critical Care Medicine – reality and perspectives
311 Study of personality characteristics in critical patients
312 Treatmentof post-critical depression
313 “The Other”Critical Medicine of the 21stCentury-The Problems of Management
314 Serotonin in critical patients
315 The impact of sound waves on brain blood circulation in unconscious critical patients
316 Study of Memory and intellectual assessment of critical patients
317 Formation of “Anesthesiology-Reanimatology” and “Critical medicine” in Georgia
318 Multistage surgery in treatment of patients in a critical condition
319 The New treatment for critical patients Medicine-results of bone marrow electrostimulation
320 Features of spinal anesthesia in the elderly critical patients wich limited resources
321 Multi-stimulant for critical patients
322 Used off plazmapheresis in critical patients
323 The The standard of surgical treatment of intracerebral hematomas
324 Information about the human head and brain transplant is under progress
325 EEG disorders in orthodox Christian religious praying in unconscious critical patients
326 Сравнение прогнозирующего значения интегральных систем SOFA и PIM в детском возрасте при сепсисе
327 Analysis of bone marrow from patients in critical condition
328 Treatment of patients with pneumonia in critical conditions by means of plasma flow
329 Влияние сочетанного применения плазменной радиации, электростимуляций и нитроглицерина на преკურსორные клетки при критических состояниях
330 Влияние электрической стимуляции на прекурсорные клетки при критических состояниях
331 Лечебная эндоскопия при кровотечениях из верхних отделов желудочно-кишечного тракта у критических больных
332 Лечебная бронхоскопия при вентилятор-ассоциированных пневмониях у больных в критических состояниях
333 Разработка критериев для создания рабочих программ клиник критической медицины
334 პროგენიტული პრეკურსორების კომიტირება პოსტრეანიმაციული დაავადებისას
335 პლაზმური სხივების გამოყენება კუჭისა და თორმეტგოჯა ნაწლავის მწვავე წყლულების მკურნალობის მიზნით ფილტვების ხელოვნურ ვენტილაციაზე მყოფ ავადმყოფებში
336 პლაზმური სხივების გამოყენება ავადმყოფებში რესპირატორ-ასოცირებული პნევმონიების პრევენციისა და მკურნალობისათვის კრიტიკულ მდგომარეობათა დროს
337 ვირუსული მენინგოენცეფალიტით გამოწვეული კრიტიკული მდგომარეობის მკურნალობის თავისებურებები
338 სიკვდილის „დაბადების” რუტინულ პროცესებში ბორელიების ანტიგენების სავარაუდო მონაწილეობის შესახებ
339 ძვლის ტვინის ელექტროსტიმულაცია - მკურნალობის ახალი მეთოდი კრიტიკული ავადმყოფებისათვის
340 კრიტიკულ ავადმყოფთა მკურნალობის შორეული შედეგები
Nothing found.
ზვ. ხელაძე
No biographical information has been added yet.
1 Using Plasma Radiations at Prevention and Treatment of the Critically Ill Patients With Ventilator Associated Pneumonia
2 The Tactics of Treating Stress Ulcers In The Patients Who Are on Mechanical Ventilation
3 Postoperative Hospital Acquired Infections
4 პანდემია,რომელსაც არ ელოდნენ
5 პანდემიების მიერ შექმნილი ისტორია
6 ვირუსის ორგანიზმში ჩანერგვის პროცესი
7 ახალი კორონა ვირუსების აგრესიული ბუნება
8 ეპიდსაწინააღმდეგო ღონისძიებები
9 დიაგნოზის სირთულენი
10 მკურნალობის მართვა
11 ვაქცინით მოტანილი იმედი
12 პოსტკოვიდური სინდრომი
13 მომავალი კატასტროფები-ახალი ნატო 21-ე საუკუნის მსოფლიოსათვის
14 კოლონოსკოპია მსხვილი ნაწლავის პოლიპური წარმონაქმნების დიაგნოზირებისა და მკურნალობის დროს
15 ავადმყოფთა თავის ტვინის ელექტროსტიმულაციის პირველი შედეგები
16 ავადმყოფთა მეხსიერების შესწავლა კრიტიკულ მდგომარეობათა დროს და მის მემდგომ პერიოდში
17 ინფექციური გართულებების პრევენციისა და მკურნალობის ახალი ტექნოლოგიები პლაზმური ნაკადის ტექნიკის მაგალითზე
18 პოსტკოვიდური სინდრომი
19 პლაზმური სხივების გამოყენების ქვედა კიდურების ჩირქოვანი გათულებების სამკკურნალოდ
20 საქართველოს კრიტიკული მედიცინის ინსტიტუტში მიღებულ მეცნიერულ სიახლეთა რეტროსპექტული ანალიზი
21 პრემორბიდულ მედიცინის ავადმყოფთა მკურნალობის შედეგები საქართველოს კრიტიკული მედიცინის ინსტიტუტში
22 სიკვდილის პრობლემათა ახალი ხედვა
23 Zvlis tvinis ელექტროსტიმულაცია kritikul mdgomareobaTa dros
24 სახელმძღვანელო სეფსისის შესახებ კრიტიკული მედიცინის ექიმებისათვის
25 სურათები „კვანტური მედიცინისთვის“
26 ავადმყოფთა ინტელექტუალური შესაძლებლობებისა და მეხსიერების შესწავლა კრიტიკულ მდგომარეობათა დროს
27 ,,Deja Vus” ფენომენის გამოვლინების თავისებურებანი კრიტიკულ მდგომარეობათა დროს
28 „Jame Vus” ფენომენის გამოვლინების თავისებურებანი კრიტიკულ მდგომარეობათა დროს
29 სიახლე დაავადებათა მკურნალობაში: ძვლის ტვინის პროგენიტური პრეკურსორების კომიტირება
30 One year since the announcement of the New Corona Virus pandemic: reality and prospects
31 A pandemic, that was not expected
32 The use of argon plasma flow in the complex treatment of pneumonia in critically ill patients on artificial lung ventilation
33 Comparative analysis of extracorporeal hemoperfusion methods
34 Study of immune memory induced by immunocompetent T-lymphocytes in critical conditions
35 Electrical stimulation of the bone marrow should become an essential component of the treatment process for critically ill patients.
36 Named the "Death Factor" cytokine - is it possible for it to be involved in the act of sudden death in those infected with the New Corona Virus?
37 "New NATO" for the world of the 21st century
38 Peculiarities of treatment of the patients infected with the "SARS-CoV-2" virus.
39 However, only one “SARS-CoV-2 “virus has been identified by the World Health Organization as a cause of the “COVID-19 pandemic”,but at least three different strains of the same virus have been reported to work during the pandemic
40 Analysis of the work of the Medical Service of Georgia from the “Developed Socialism,s Era" before the onset of the "COVID-19" pandemic, caused by "SARS-Cov-2" virus
41 „ახალი სიკვდილი” და „ახალი სიცოცხლე”
42 ენდოგენური ტოქსემიის სადიაგნოზო სწრაფი, მარტივი და იაფი მეთოდი
43 Plasma flow treatment of the diabetic foot
44 Conceptual opinions related to the scientific reasersh journal "Critical Care& Catastrophe Medicine" 60-61 numbers
45 Peculiarities changes the number of immune-competent T- and B- lymphocytes during dying process
46 Study of the number of T- and B- lymphocytes in adults and elderly dying’s patients
47 Number of the rosette forming cells in different sex patients during dying process
48 Study of dying patients responder cells activity in the lymphocytes one direction primery mixed culture
49 Study of responder cells activity in the lymphocytes one direction primery mixed culture in adults and elderly dying patients
50 Study of responder cells activity in the lymphocytes one direction primery mixed culture in different sexes dying patients
51 Study of dying patients immune memomry cells activity in the lymphocytes one direction secondary mixed culture
52 Study of immune memory cells activity in the one direction segondery mixed culture lymphocytes in adults and elderly dying patients
53 Study of immune memory cells activity in the one direction segondery mixed culture lymphocytes in different sexes dying patients
54 Study of blood serum concentration A,M and G immunoglobulins during dying process
55 Study of blood serum concentration A, M and G immunoglobulins in adult and elderly dying patients
56 Study of blood serum concentration A, M and G immunoglobulins in different sexes dying patients
57 Study of mitogen activity T-lymphocytes in patients during dying process
58 Study of mitogen activity T- lymphocytes in adults and elderly patients diuring dying process
59 Study of mitogen activity T- -lymphocytes in different sexes patients duiring dying process
60 Study of suppressor lymphocytes activity in patients diuring dying process
61 Study of suppressor lymphocytes activity in adults and elderly patients diuring dying process
62 Study of suppressor lymphocytes activity in different sexes patients duiring Dying process
63 Study of immune response cheing during dying process which death and revived patients
64 Study of immune response changes in the experimental dogs during morbidity process through bleeding
65 Study of immune response changes in the experimental dogs during dying process,which modelded by short and long formes through bleeding from femoral artery
66 Mildronate restores elderly persons T-lymphocytes ability to generate E-rosettes cells
67 Mildronate restores T-Lymphocytes E-rosettes forming function of the critical Patients.
68 Siofor restores elderly persons T-lymphocytes ability to generate E-rosettes cells
69 Siofor restores T-Lymphocytes E-rosette forming function of the critical Patients
70 Nitroglycerin restores elderly persons T-lymphocytes ability to generate E-rosettes cells
71 Nitroglycerin restores T-Lymphocytes E-rosette forming function of the critical Patients
72 Adrenalin don’t restores elderly persons T-lymphocytes ability to generate E-rosettes cells
73 Adrenalin don’t restores T-Lymphocytes E-rosette forming process of the critical Patients
74 Dexametason suppresses elderly persons T-lymphocytes ability to generate E-rosettes cells
75 Dexametason suppresses T-Lymphocytes E-rosette forming process of the critical patients
76 Furosemyd suppresses elderly persons T-lymphocytes ability to generate E-rosettes cells
77 Cordaron suppresess elderly persons T-lymphocytes ability to generate E-rosettes cells
78 Cordaron suppresses T-Lymphocytes E-rosette forming process of the critical patients
79 Furosemyd suppresess elderly persons T-lymphocytes ability to generate E-rosettes cells
80 Furosemyd suppresses T-Lymphocytes E-rosette forming process of the critical patients
81 Verampamyl suppresses elderly persons T-lymphocytes ability to generate E-rosettes cells
82 Verampamil suppresses T-Lymphocytes E-rosette forming process of the critical patients
83 Dopamine don’t restores elderly persons T-lymphocytes ability to generate E-rosettes cells
84 Dopamine don,t restores critical patients T-lymphocytes ability to generate E-rosettes cells
85 Dobutamyne don’t restores elderly persons T-lymphocytes ability to generate E-rosettes cells
86 Dobutamine don’t restores critical patients T-lymphocytes ability to generate E-rosettes cells
87 Noradrenalin don’t restores elderly persons T-lymphocytes ability to generate E-rosettes cells Critical Care&Catastrophe Medicine ", Tbilisi, Georgia,2019, N58-59
88 Noradrenalin don,t restores critical patirnts T-lymphocytes ability to generate E-rosettes cells
89 Diazepam don,t restores elderly persons T-lymphocytes ability to generate E-rosettes cells
90 Diazepam don,t restores critical patients T-lymphocytes ability to generate E-rosettes cells
91 Propophol don,t restores elderly persons T-lymphocytes ability to generate E-rosettes cells
92 Propophol don’t restores critical patients T-lymphocytes ability to generate E-rosettes cells
93 Ketamyn don,t restores elderly persons T-lymphocytes ability to generate E-rosettes cells
94 Ketamyn don,t restores critical patients T-lymphocytes ability to generate E-rosettes cells
95 Midazolam don,t restores elderly persons T-lymphocytes ability to generate E-rosettes cells
96 Mydazolam Diazepam don,t restores critical patirnts T-lymphocytes ability to generate E-rosettes cells
97 Movalys don,t estores elderly persons T-lymphocytes ability to generate E-rosettes cells
98 Movalys don,t restores critical patirnts T-lymphocytes ability to generate E-rosettes cells
99 Aspirin suppresses critical patients T-lymphocytes ability to generate E-rosettes cells
100 Thiopental suppresses T-Lymphocytes E-rosette forming process of the elderly patients
101 Thiopental suppresses T-Lymphocytes E-rosette forming process of the critical patients
102 Sulphat Magnya don’t restores elderly persons T-lymphocytes ability to generate E-rosettes cells
103 Sulphat Magnya don,t restores T-Lymphocytes E-rosette forming process of the critical Patients
104 Aspirin suppresses elderly persons T-lymphocytes ability to generate E-rosettes cells
105 Aspirin suppresses T-Lymphocytes E-rosette forming process of the critical patients
106 Recormon restores elderly persons T-lymphocytes ability to generate E-rosettes cells
107 Recormon restores T-Lymphocytes E-rosettes forming function of the critical Patients
108 The second option rule of receiving "Death factor"
109 The first option rule of receiving "Death factor"
110 Study of lethal and divergent effect of "Death factor"
111 Creation of antitoxin and immunoglobulin against the "Death factor"
112 Comparative analysis of immunosorbtion in various phases of sepsis treatment process
113 Inspection of against "Death factor" antitoxin and immunoglobulin rejuvenating effect in the old age
114 Inspection against of the "Death factor"antitoxin and immunoglobulin rejuvenating effect
115 Study of anti-aging effect of antitoxin and immunoglobulin against the "Death factor"
116 Peculiarities of the "Death factor" change in morbidity and resuscitation
117 Which CD markers do old lymphocytes lose during critical care conditions What causes of aging of lymphocytes of critical patients
118 Which CD markers do old lymphocytes lose during critical care conditions? What causes of aging of lymphocytes of critical patients
119 What causes of aging of lymphocytes of critical patients Critical Care Medicine Institute, Tbilisi, Georgia
120 Lymphocytes of critical patients are older than healthy ones
121 What causes of aging of lymphocytes of critical patients
122 Critically ill patients blood plasma causes aging young white mouse
123 Blood plasma of old ages persons does not suppress of the respondent cells activity in the one direction mixed culture of lymphocytes during the participation of anti lethal immunoglobulin
124 Blood plasma of old ages persons suppresses the respondent cells activity in the one direction mixed culture of lymphocytes
125 Old ages persons blood plasma causes aging young white mouse
126 "Death Factor " can not suppress the respondent cells activity in one direction mixed culture of lymphocytes during the participation of anti lethal immunoglobulin
127 Blood plasma of critical patients does not suppress of the respondent cells activity in the one direction mixed culture of lymphocytes during the participation of anti lethal immunoglobulin
128 Blood plasma of critical patients suppresses the respondent cells activity in the one direction mixed culture of lymphocytes
129 The "Death factor” causes aging of the young white mouse
130 Critically ill patients blood plasma dos not causes aging young white mouse after processing witch anti lethal immunoglobulin
131 The "Death factor” after proceeding anti lethal immunoglobulin don’t aging of the young white mouse
132 Old ages persons blood plasma dos not causes aging young white mouse, after processing witch anti lethal immunoglobulin
133 Young ages persons blood plasma stops the aging process of old ages white mouse
134 Old ages persons blood plasma after proceeding “Death Factor” causes aging young white mouse
135 Young ages persons blood plasma after proceeding from “Death Factor” don’t stops the aging process of old ages white mouse
136 Young ages persons blood plasma after proceeding from anti lethal immunoglobulin stops the aging process of old ages white mouse
137 The "Death Factor" suppresses respondent cells in the one direction lymphocytes mixed culture
138 Problems of preparation personals for Critical Medicine in XXI century
139 Peculiarities changes stem and immunocompetent cells by nitroglycerin action on the critical patient’s bone marrow
140 Results of treatment critical ill patients by after other factors action on the bone marrow
141 Peculiarities changes peripheral blood cells by plasma ray action on the critical patient’s bone marrow
142 Peculiarities changes Acid- alkyls ------ by plasma ray action on the critical patient’s bone marrow
143 Peculiarities changes stem and immunocompetent cells by electrical impulses action on the critical patient’s bone marrow
144 Peculiarities changes periphereal blood cells by electrical impulses action on the critical patient’s bone marrow
145 Peculiarities changes Acid- alkyls ----- cells by electrical impulses action on the critical patient’s bone marrow
146 Peculiarities changes bone marrow cells by nitroglycerin action on the critical patient’s bone marrow
147 პერიფერიული სისხლის უჯრედების ცვლილებათა თავისებურებანი კრიტიკულ ავადმყოფთა ძვლის ტვინის ნიტროგლიცერინით დამუშავების შემდეგ
148 ძვლის ტვინის მჟავა-ტუტოვანი წონასწორობის ცვლილებათა თავისებურებანი კრიტიკულ ავადმყოფთა ძვლის ტვინის ნიტროგლიცერინით დამუშავების შემდეგ
149 ძვლის ტვინის უჯრედების რაოდენობის ცვლილებათა თავისებურებანი კრიტიკულ ავადმყოფთა ძვლის ტვინის ადრენალინით დამუშავების შემდეგ
150 ღეროვან და იმმუნოკომპეტენტურ უჯრედების ცვლილებათა თავისებურებანი კრიტიკულ ავადმყოფთა ძვლის ტვინის ადრენალინით დამუშავების შემდეგ
151 Death in critical care medicine clinic
152 Does Dark matter cause sudden death and does it kill 18 year old climber - case analysis after 35 years Georgian Critical Care Medicine Institute Proceedings of the Scientific Conference of the Georgian Academy of Medical Scie
153 What information do patients recall in life-threatening conditions better: new or old, positive or negative?
154 The Project of Poverty Reduction Program of Three Years for Georgia Georgian Critical Care Medicine Institute
155 A new method of treating critical conditions presented as electrical stimulation of the bone marrow, that can be used to treat many other diseases.
156 Human DNA must contain codes other than the protein code. that allow each cell's chromosome apparatus to store all the information in the universe
157 Standard requirements of treatment of acute mediastinitis for critical care medicine clinics of limited resources
158 Standard requirements of treatment of meningitis, encephalitis and meningoencephalitis for Critical Care Medicine clinics with limited resources
159 Standard requirements of treatment of Myasthenic Crisis for critical care medicine clinics of limited resources
160 Standard requirements of treatment of Myxoma for Critical Care Medicine clinics with limited resources
161 Standard requirements of treatment of Freezing injury for Critical Care Medicine clinics with limited resources
162 Standard requirements of treatment of Large intestine’s diseases For critical care medicine clinics of limited resources
163 Standard requirements of Sun-related injuries treatment of sun-related injuries for Critical Care Medicine clinics with limited resources
164 Standard requirements of treatment of Nelson Syndrome and Symonds disease for critical care medicine clinics of limited resources
165 Standard requirements of treatment of Pregnant and obstetric patients for Critical Care Medicine clinics with limited resources
166 Standard requirements of treatment of acute pancreatitis for critical care medicine clinics of limited resources
167 Standard requirements of treatment of parathyroid Stroke for critical care medicine clinics of limited resources
168 Standard requirements of treatment of acute peritonitis for critical care medicine clinics of limited resources
169 Standard requirements of treatment of acute pneumonia for critical care medicine clinics of limited resources
170 Standard requirements of treatment of Poliomielitys for Critical Care Medicine clinics with limited resources
171 Standard requirements of treatment of postreanimation Disease for critical care medicine clinics of limited resources
172 Standard requirements of treatment of Cholera for critical care medicine clinics of limited resources
173 Standard requirements of treatment of Adult’s Respiratory Distress Syndrome for Critical Care Medicine clinics with limited resources
174 Standard requirements of treatment of Rickettsioses for critical care medicine clinics of limited resources
175 Standard requirements of treatment of Liver failure for Critical Care Medicine clinics with limited resources
176 Standard requirements of treatment of Obstruction of Respiratory Way for critical care medicine clinics of limited resources
177 Standard requirements of treatment of Esophageal diseases for critical care medicine clinics of limited resources
178 Standard requirements of treatment of sepsis for Critical Care Medicine clinics with limited resources
179 Standard requirements of treatment of HIV infection for critical care medicine clinics of limitedresources
180 Standard requirements of treatment of Febrile Schizophrenia for critical care medicine clinics of limited resources
181 Standard requirements of treatment of Blood Disease for critical care medicine clinics of limited resources
182 requirements of treatment of Thermal attack and overheating for Critical Care Medicine clinics with limited resources
183 Standard requirements of treatment of Fungi for critical care medicine clinics of limited resources
184 Standard requirements of treatment of Severe Spinal Trauma for Critical Care Medicine clinics with limited resources
185 Standard requirements of treatment of severe skull and brain trauma for Critical Care Medicine clinics with limited resources
186 Standard requirements of treatment of acute radiant disease for critical care medicine clinics of limited resources
187 Standard requirements of treatment of diabetes insipidus for critical care medicine clinics of limited resources
188 Standard requirements of treatment of Tetanus for critical care medicine clinics of limited resources
189 Standard requirements of care and treatment of vegetativ condition for Critical Care Medicine clinics with limited resources
190 Standard requirements of treatment of Acute Failure of the Cortex of the Adrenal Gland for critical care medicine clinics of limited resources
191 Standard requirements of treatment of small intestine’s diseases for critical care medicine clinics of limited resources
192 Standard requirements of treatment of Kidney failure for Critical Care Medicine clinics with limited resources
193 Standard requirements of treatment of Poisoning for Critical Care Medicine clinics with limited resources
194 Standard requirements of treatment of Embola for critical care medicine clinics of limited resources
195 Standard requirements of treatment of Smallpox for Critical Care Medicine clinics with limited resources
196 Standard requirements of treatment of Tuberculosis for critical care medicine clinics of limited resources
197 Standard requirements of treatment of Primary and second hyperaldostrenism for Critical Care Medicine clinics of limited resources
198 Standard requirements of treatment of acute porfiria for critical care medicine clinics of limited resources
199 Standard requirements of treatment of Aneurism and Thrombosis for Critical Care Medicine clinics with limited resources
200 Standard requirements of treatment of anemia for critical care medicine clinics of limited resources
201 Standard requirements of treatment of Arrhythmias and Blockades for Critical Care Medicine clinics with limited resources
202 Standard requirements of treatment of status astmaticus for critical care medicine clinics of limited resources
203 Standard requirements of treatment of Neonatal Disorders for Critical Care Medicine clinics with limited resources
204 Standard requirements of treatment of hydrophobia for critical care medicine clinics of limited resources
205 Standard requirements of treatment of Diabetes coma for critical care medicine clinics of limited resources
206 Standard requirements of treatment of Burn Diseases for critical care medicine clinics of limited resources
207 Standard requirements of treatment of Eclampsy for critical care medicine clinics of limited resources
208 Standard requirements of treatment of Injury from electric current for Critical Care Medicine clinics with limited resources
209 Standard requirements of treatment of spleen diseases for critical care medicine clinics of limited resources
210 Standard requirements of treatment of Embola for critical care medicine clinics of limited resources
211 Standard requirements of treatment of epileptic status for Critical Care Medicine clinics with limited resources
212 Standard requirements of treatment of Echinoccocus for critical care medicine clinics of limited resources
213 Standard requirements of treatment of thyroid stroke for critical care medicine clinics of limited resources
214 Standard requirements of treatment of for Pheochromocytoma critical care medicine clinics of limited resources
215 Standard requirements of treatment of Pulmonary Embolism for critical care medicine clinics of limited resources
216 Standard requirements of treatment of Pulmonary Congestion for critical care medicine clinics of limited resources
217 Standard requirements of treatment of Flu for critical care medicine clinics of limited resources
218 Standard requirements of treatment of“Guillain-Barre” Syndrome for Critical Care Medicine clinics with limited resources
219 Standard requirements of treatment of Flu for critical care medicine clinics of limited resources
220 Standard requirements of treatment of Heart Diseases for critical care medicine clinics of limited resources
221 Standard requirements of treatment of Cardiac Arrest for critical care medicine clinics of limited resources
222 Standard requirements of treatment of severe chest trauma for critical care medicine clinics of limited resources
223 Standard requirements of treatment of Hemorrhagic Fever for critical care medicine clinics of limited resources
224 Standard requirements of treatment of Hepatitis for critical care medicine clinics of limited resources
225 Standard requirements of treatment of Hypothalamic-Hypophysal Coma for critical care medicine clinics of limited resources
226 Standard requirements of treatment of Skin Daises for critical care medicine clinics of limited resources
227 Standard requirements of treatment of Cardiogenic Shock for critical care medicine clinics of limited resources
228 Standard requirements of treatment of Cardiomyopathfor Critical Care Medicine clinics with limited resources
229 Standard requirements of treatment of Collagenoses Diseases for critical care medicine clinics of limited resources
230 Standard requirements of treatment of long-term crush syndrome for critical care medicine clinics of limited resources
231 Standard requirements of treatment of Cushing diseaseC and Cushing syndrome for critical care medicine clinics of limited resources
232 Standard requirements of treatment of gastric disease for critical care medicine clinics of limited resources
233 Standard requirements of treatment of legionellosis for critical care medicine clinics of limited resources
234 Standard requirements of treatment of leishmaniasis for critical care medicine clinics of limited resources
235 Standard requirements of treatment of Malaria for critical care medicine clinics of limited resources
236 Standard requirements of treatment of Hypovolemic shock for Critical Care Medicine clinics with limited resources
237 Modern methods of anesthesia in endoscopic research methods and treatment of patients in critical condition
238 Actual issues of anesthetic management optimization in therapeutic and diagnostic bronchoscopy among patients in critical condition Institute of Critical Care Medicine, Tbilisi, Georgia
239 Results of transplantation of brain cells of mice embryo in postreanimation period
240 Pecularities of hemostatic changes in critical patients of acute respiratory failure and acute cardiac failure
241 Pecularities of hemostatic changes in critical patients of chronic cardiac failure Critical Care
242 Disorders in memory during critical conditions Critical Care Medicine Institute, Tbilisi, Georgia
243 Immunosorbtion-The new technology treatment of sepsis. Critical Care Medicine Institute,Tbilisi,Georgia
244 Treatment of sepsis by the blood extracorporeal perfusion in the activated charcoal immunosorbent
245 Peculiarities of hemostasis’s changes in critical patients of hemorrhagic insult Critical Care Medicine Institute,Tbilisi,Georgia
246 Functional condition of kidneys in critical patients of chronic cardiac failure Critical Care Medicine Institute,Tbilisi,Georgia
247 Peculiarities of kidney function in critical patients of hemorrhagic insult
248 Peculiarities of kidney function in critical patients of ischemic insult
249 Functional condition of kidneys in critical patients of acute respiratory failure and chronic cardiac failure
250 Electric stimulation of brain-will it be a standard method of treatment of critical patients
251 Pecularities of changes in liver function of critical care patients which suffer from hemorrhagic insult
252 Peculiarities of changes in liver function of critical care patients which suffer from ischemic insult
253 Peculiarities of changes in liver function of critical care patients which suffer from cardiac failure
254 Peculiarities of changes in liver function of critical care patients which suffer from acute respiratory failure
255 Peculiarities of changes in liver function of critical care patients which suffer from acute respiratory failure and cardiac failure
256 The Predictors of Death
257 Works of third step for creation artificial intelligence
258 Requirements for providing technological process for critical care medicine service of limited resources
259 Anti-death immunoglobulin treatment and prophylactic effect in experiment
260 Electric-encephalographic changes by the influence of sound waves in unconscious critical patients
261 Plasma flow treatment of the acute gastro-duodenal ulceration at ventilator-dependent patients
262 Two cases of the neuroleptic malignant syndrome
263 Progress report of the critical care medicine institute’s clinic in 2009
264 Progenitor precursors' committing at critical stroke
265 Progenitor precursors’ committing at post-reanimation disease
266 Distinctives of medical assistance for the old-aged critical patients
267 Critical care medicine resources’ program design
268 Genetic and psychological basis of a frequent usage of the word “cool” in human speech
269 In the own cell chromosome apparatus of human might be kept all universes information
270 Long-term results of treatment of critical patients
271 Medicine, that needs to be treated itself
272 Mitochondria”, that is “observer” and takes out the energy in the universe
273 New data of the results of bone marrow electro stimulation in treatments of patients with critical health situation
274 Participation of borealis antigens in a routine of death birt
275 Studying of a person’s character and destiny peculiarities in Critical Care Medicine personnel
276 Studying of the prophylactic effect of anti death anatoxin
277 The impact of the cost on treatment process for treatment results of the critical patients
278 The impact of the manegment systems for the critical patients treatment results
279 The influence of working conditions on Short and long term memory of Critical Care Medicine personnel
280 Information about the feasibility of transplanting brain and spinal cord with a together complex
281 ,,Death Code”-which ,,Lives” during life and kills this life
282 Georgia has great achievements in the sphere of arranging critical care medicine services but there are lot of issues which must be done ahead
283 However, the soul do not constitute unknown energy type that has mentality, but it is still should be studied
284 Peculiarities of providing anesthesia in old age critical patients
285 Peculiarities of Surgical Treatment in Critical Patients of old age
286 Peculiarities of treatment of critical insult of old age
287 Research of optimal ways for providing oxygen in behalf of critical medicine
288 Studying of function and morphology of thyroid gland in critical patients
289 Studying of function and morphology of Heart and Liver in co-workers of the critical care medicine
290 Studying of function and morphology of thyroid gland in critical patients
291 The influence of music waves on brain in critical patients in unconscious condition
292 The internet has throughly changed the everyday routine of critical care medicine service
293 The problems of critical care medicine
294 Virus hepatitis markers’ distribution between the clinic of Georgian Institute of Critical Care Medicine and medical personal
295 Human can have inverted data at the time of birht about passed way of ancestors as well as about his personal life ,,scenario” on the way to go along descendants
296 Analysis of critical pneumonia multicenter studies under the auspices of the European Society of Intensive Care Medicine conducted in Critical Medicine Institute of Georgia
297 Bone marrow electro stimulation shall become a standard treatment for criticalpatients
298 Brain electrical activity manifestation in orthodox christian patients diuring praying
299 Conceptual Considerations Instead of Introduction
300 Dopamine quantity study in critical patients
301 EEG changes in critical patients
302 Influence of music on EEG of critical patients
303 Memory and intellect assessment of critical patients
304 Pecularitis of Surgical treatment of intracereebral hemorage
305 Remote control systems for Critical Care Medicine – reality and perspectives
306 Study of personality characteristics in critical patients
307 Treatmentof post-critical depression
308 “The Other”Critical Medicine of the 21stCentury-The Problems of Management
309 Serotonin in critical patients
310 The impact of sound waves on brain blood circulation in unconscious critical patients
311 Study of Memory and intellectual assessment of critical patients
312 Multistage surgery in treatment of patients in a critical condition
313 The New treatment for critical patients Medicine-results of bone marrow electrostimulation
314 Features of spinal anesthesia in the elderly critical patients wich limited resources
315 Multi-stimulant for critical patients
316 Used off plazmapheresis in critical patients
317 The The standard of surgical treatment of intracerebral hematomas
318 EEG disorders in orthodox Christian religious praying in unconscious critical patients
319 Analysis of bone marrow from patients in critical condition
320 Treatment of patients with pneumonia in critical conditions by means of plasma flow
321 Влияние сочетанного применения плазменной радиации, электростимуляций и нитроглицерина на преკურსორные клетки при критических состояниях
322 Влияние электрической стимуляции на прекурсорные клетки при критических состояниях
323 Лечебная эндоскопия при кровотечениях из верхних отделов желудочно-кишечного тракта у критических больных
324 Лечебная бронхоскопия при вентилятор-ассоциированных пневмониях у больных в критических состояниях
325 Разработка критериев для создания рабочих программ клиник критической медицины
326 დიაბეტური ტერფის მკურნალობა პლაზმური ნაკადით
327 მონაცემები კრიტიკული მედიცინის კლინიკის მუშაობის დაგეგმარებისათვის.
328 პროგენიტული პრეკურსორების კომიტირება პოსტრეანიმაციული დაავადებისას
329 პლაზმური სხივების გამოყენება კუჭისა და თორმეტგოჯა ნაწლავის მწვავე წყლულების მკურნალობის მიზნით ფილტვების ხელოვნურ ვენტილაციაზე მყოფ ავადმყოფებში
330 პლაზმური სხივების გამოყენება ავადმყოფებში რესპირატორ-ასოცირებული პნევმონიების პრევენციისა და მკურნალობისათვის კრიტიკულ მდგომარეობათა დროს
331 სიკვდილის „დაბადების” რუტინულ პროცესებში ბორელიების ანტიგენების სავარაუდო მონაწილეობის შესახებ
332 ძვლის ტვინის ელექტროსტიმულაცია - მკურნალობის ახალი მეთოდი კრიტიკული ავადმყოფებისათვის
333 კრიტიკულ ავადმყოფთა მკურნალობის შორეული შედეგები
Nothing found.
დ. ხელაძე
No biographical information has been added yet.
1 Разработка критериев для создания рабочих программ клиник критической медицины
Nothing found.
ი. ხელია
No biographical information has been added yet.
1 Stenting of the left main bronchus in cicatrical post-TB bronchial stenosis
Nothing found.
თამთა ხელიძე
No biographical information has been added yet.
1 აქტიური ცხოვრებიდან სრულ უმოძრაობამდე - გიიენ-ბარეს სინდრომი
2 მრავლობითი სკლეროზი
Nothing found.